Haemonetics Shares Rise On Supply Agreement With CSL Plasma
Dow Jones2026/08/18 14:58By Anvee Bhutani
Haemonetics shares rose in Tuesday morning trading after the company said it entered into a supply agreement with CSL Plasma for its NexSys PCS devices and related disposables in the U.S.
Shares of the company were recently up 15% at $104.22.
Under the non-exclusive agreement, CSL may use Haemonetics' NexSys PCS devices with Persona PLUS technology and purchase related disposables.
Haemonetics expects CSL to transition a portion of its U.S. plasma-collection centers to the devices, though the scope and timing of the rollout have not yet been determined. The agreement doesn't include minimum purchase commitments.
Haemonetics said it isn't updating its fiscal 2027 guidance at this time and expects to provide an update on the agreement's anticipated impact on results during its fiscal second-quarter earnings call in November.
Write to Anvee Bhutani at anvee.bhutani@wsj.com
(END) Dow Jones Newswires
August 18, 2026 10:58 ET (14:58 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Kona BidCo raises Zalaris stake to 87.34% after buying 2,337 shares at NOK 100 apiece
Venice and Morpheus tokens climb as US ban on Anthropic's Fable 5 fuels 'permissionless AI' pitch
Princeton Critical Minerals raises $16 million to scale lithium production from brine
Kohl's Traffic is Growing Again, Report Says -- Market Talk
Crypto prices
More
